Benzodiazepines: Overdose Trends and Judicious Prescribing Guidelines – The New York City Experience
Presented by: Jessica Kattan, MD, MPH, Director – Primary Care Integration Unit
Bureau of Alcohol and Drug Use Prevention, Care and Treatment, New York City Department of Health and Mental Hygiene
Denise Paone, EdD, Senior Director of Research and Surveillance, Bureau of Alcohol and Drug Use Prevention, Care and Treatment, New York City Department of Health and Mental Hygiene
Krishika Graham, MD, Medical Epidemiologist, New York City Department of Health and Mental Hygiene
Sponsored by: Opioid Post-Marketing Requirements Consortium (OPC)/Campbell Alliance (Purdue Pharma, LP; Actavis; Endo Pharmaceuticals; Janssen Pharmaceuticals; Mallinckrodt, LLC; Pfizer; Rhodes Pharmaceuticals, LP; Roxane Laboratories; and Zogenix), Clinical Directors Network, Inc.(CDN), N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667) – This webcast is pending for up to 1.5 Prescribed credits by the American Academy of Family Physicians (AAFP)
Additional Resources:
- City Health Information – Judicious Prescribing Guidelines of Benzodiazepines [CLICK HERE]
- Buprenorphine infrequently found in fatal overdose in New York City [CLICK HERE]